±±Ê¦´óϸ°ûÉúÎïѧ£¨ÀúÄêÊÔÌâ×ܽᣩ j0(+Kq:J
Ò»¡¢ Ãû´Ê½âÊÍ£º wK*b2r}0/
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© tj<0q<is
2£® PCR£¨96£© l(A>Rw|
3£® ·ºËØ£¨ubquitin£©£¨96£© \0bZ1"
4£® °é·Ö×Ó£¨chapron£©£¨96£© iJ%`ym4Y
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© W^T6^q5;H
6£® DG£IP3£¨96£© Ks/Uyu. X
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© xA#'%|
"
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© |$QL>{81
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© rvw
fQ'14
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© a";xG,U
11£® Transformation£¨92£© =7P(T`j
12£® TransfectionתȾ£¨92£© >XomjU[srQ
13£® Transcytosis×ªÒÆ×÷Óã¨92£©
1}DUe.a
14£® Transductionתµ¼£¨92£©
5;yVA
15£® Transdetermination£¨92£© 4
K<T_B/
16£® Transdifferentiation£¨92£© jb
{5
17£® Transgenic animalת»ùÒò¶¯Î92£© P;~P:qKd
18£® Rb£1£¨92£© P6([[mmG
19£® P53£¨92¡¢91£© "~=\AB=+Z
20£® C£jun£¨92£© cd?a rIV5
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© BdYl
sYp
22£® °ûÄÚÌ壨99£© @"$rR+r'
23£® Cyclin dependent kinase inhibitor(CDKI)(99) [-*8S1
24£® G£protein£¨91£© ckg8x&Z
25£® Restriction point£¨91£© u*C"d1v=
26£® Antipost£¨91£© HZ.Jc"+M
27£® Capping£¨91£© {I~[a#^
28£® TATAbox£¨91£© MI<XLn!*
29£® cDNA library£¨90£© u,Rhm-`
30£® Aritotic apparatus£¨90£© eHy.<VX
31£® ¿çĤÐźŠtransmembrane signal£¨90£© JJn+H&[B
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© r")zR,
33£® Nuclear lamina£¨90£© my(yN|
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© c$
w} h[
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© 0Fi&7%
36£® ϸ°û·Ö»¯£¨00£© Vy:MK9U2
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© ^68BxYUoD\
38£® ¿Ë¡£¨00£© fpK`
39£® »ùÒò×飨00£© ;n-IpR#|
40£® Caspase£¨00£© _-.~>C
41£® ת¼Òò×Ó£¨00£©
7L=V{,,v
42£® ÅßÌ¥¸Éϸ°û£¨01£© / Dn
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© Q,
!b
44£® DNAоƬ£¨01£© v8L&F9
o
¶þ¡¢ ÎÊ´ðÌ⣺ (KDv>@5
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© )5M9Ro7
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æä¹¦ÄÜ£¨95£© &3;yho8v@
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© ecI[lB
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© G3G"SJ np
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© 8/|~E
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© A-dL_3
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© F
;m1I+;
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© G *
f5B
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© VK)K#!O8
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿ØÏ¸°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© )n[ oP%
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷ÍÆ¶¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© N!e?K=}tL
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© *<**rY*
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© t7%!~s=,M
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© B0:[3@P7
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹ØÏµ£¨95£©
Bkn-
OG
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© ly d[GfJ
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æä¹¦ÄÜ£¨93£© F H'jP`
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© jnK8
[och
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© I!)gXtJA"
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æä¶¨Î»¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© *yv@-lP5s
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäĿǰËùÖªµÄ¹¦ÄÜ£¨01£© ~[i,f0O,
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖØµãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© 1D fB9n
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© Z:#-4CiP
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© xy%lp{
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© dQ8}mH!
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆÚµÄµ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© H7e/6t<x
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹ØÏµ£¨91£© Musz+<]
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© "Yn<]Pa_
29£® ÊÔÊöºáÎÆ¼¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© G6zFCgFJ^y
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æä¹¦ÄÜ£¨95£© `he{"0U~S
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£©
-K`0`n}
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© P'D~Y#^
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© ;<#fZ0(l;
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© FeS6>/
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©